FMP
ShockWave Medical, Inc.
SWAV
NASDAQ
Inactive Equity
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
334.75 USD
-0.08 (-0.0239%)
SWAV Financial Statements
Year
2023
2022
2021
2020
CF from Operating Activities
196.05M
117.73M
15.04M
-71.18M
Net Income
147.28M
216M
-9.14M
-65.7M
Depreciation & Amortization
10.36M
4.86M
5.54M
3.35M
Deferred Income Taxes
14.76M
-97.28M
7.39M
487k
Stock Based Compensation
73.23M
44.89M
27.26M
10.35M
Change in Working Capital
-43.86M
-57.93M
-16.52M
-20.31M
Accounts Receivable
-41.53M
-33.31M
-25.75M
-4.31M
Inventory
-31.01M
-29.71M
-12.07M
-17.06M
Accounts Payable
112k
1.95M
1.87M
-1.39M
Other Working Capital
28.57M
3.15M
19.43M
2.45M
Other Non-Cash Items
-5.72M
7.2M
511k
646k
CF from Investing Activities
-
-
-
-
Investments in Property, Plant & Equipment
-30.59M
-25.13M
-12.44M
-11.52M
Net Acquisitions
-94.41M
37.02M
-26.42M
95.95M
Investment Purchases
-747.47M
-137.8M
-117.25M
-167.95M
Sales/Maturities of Investments
246.75M
100.77M
156.1M
72M
Other Investing Activites
-
-
-
-
CF from Financing Activities
-
-
-
-
Common Stock Issued
-
-
-
-
Common Stock Repurchased
-43k
-23k
-8.34M
-1.42M
Dividends Paid
-
-
-
-
Other Financing Activites
-
-
-
-
Free Cash Flow
165.46M
92.61M
2.6M
-82.7M
Operating Cash Flow
196.05M
117.73M
15.04M
-71.18M
Capital Expenditures
-30.59M
-25.13M
-12.44M
-11.52M
Cash at Beginning of Period
156.59M
90.87M
51.87M
140.5M
Cash at End of Period
328.42M
158.3M
90.87M
51.87M
Net Change In Cash
171.84M
67.43M
39M
-88.62M
Retained Earning Schedule
Year
2023
2022
2021
2020
Retained Earnings (Previous Year)
-36.81M
-252.81M
-243.67M
-177.97M
Net Income
147.28M
216M
-9.14M
-65.7M
Stock Repurchases
-43k
-23k
-8.34M
-1.42M
Dividend Paid
0
0
0
0
Retained Earnings
110.47M
-36.81M
-252.81M
-243.67M
Other Distributions
147.24M
215.97M
-17.47M
-67.12M
PPE Schedule
Year
2023
2022
2021
2020
Gross PPE
98.63M
80.52M
51.86M
23.93M
Annual Depreciation
10.36M
-1.42M
-6.87M
1.26M
Capital Expenditure
-30.59M
-25.13M
-12.44M
-11.52M
Net PPE
118.87M
107.06M
71.16M
34.19M
Intangible and Goodwill Schedule
Year
2023
2022
2021
2020
Acquisitions and Adjustments
39.57M
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
39.57M
0
0
0
All figures are in USD.
